header logo image

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

August 25th, 2024 2:46 am

DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that the Company will participate at the H.C. Wainwright 26th Annual Global Investment Conference in New York City.

See more here:
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Related Post

Tags:

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick